Neuberger Berman Group »

Enlivex Therapeutics shares owned by Neuberger Berman Group

Quarter-by-quarter ownership of Enlivex Therapeutics (ENLV) shares owned by Neuberger Berman Group from 13F filings

Historical chart of Neuberger Berman Group investment in Enlivex Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Enlivex Therapeutics held by Neuberger Berman Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Enlivex Therapeutics by Neuberger Berman Group

Quarter filed Position value Share count Share price at filing
2025-09-30 $11k 11k 1.04
2025-06-30 $12k 11k 1.12
2025-03-31 $14k 14k 0.97

More positions owned by Neuberger Berman Group

Microsoft Corp Common (MSFT)
Nvidia Corp Common (NVDA)
Apple Common (AAPL)
Amazon Common (AMZN)
Jpmorgan Chase & Co Common (JPM)
Alphabet Inc Class A A Common (GOOGL)
Alphabet Inc-cl C Common (GOOG)
Meta Platforms Inc Class A A Common (META)
Home Depot Common (HD)
Oracle Corp Common (ORCL)
Eli Lilly & Co Common (LLY)
Broadcom Common (AVGO)
Ishares Core S&p Etf Trust Etf-e Etf (IVV)
T Mobile Us Common (TMUS)
Berkshire Hathaway Inc Class B B Common (BRK.B)

View all positions for Neuberger Berman Group

Top funds holding Enlivex Therapeutics

Renaissance Technologies
Citadel Advisors
Susquehanna International
XTX Topco
UBS Group
Two Sigma Securities
Sigma Investment Counselors
Jane Street
Hrt Financial
Prosperity Consulting Group
Neuberger Berman Group
Two Sigma Investments
Wells Fargo & Company
Group One Trading
Steward Partners Investment Advisory

View all funds holding Enlivex Therapeutics